McKesson Co. (NYSE:MCK) announced a quarterly dividend on Wednesday, October 23rd, RTT News reports. Investors of record on Monday, December 2nd will be given a dividend of 0.41 per share on Thursday, January 2nd. This represents a $1.64 annualized dividend and a dividend yield of 1.12%.
Shares of NYSE MCK traded down $0.86 during mid-day trading on Wednesday, hitting $146.06. 1,382,178 shares of the stock traded hands, compared to its average volume of 1,972,389. The stock has a fifty day moving average price of $140.37 and a 200-day moving average price of $134.13. The company has a market cap of $27.25 billion, a price-to-earnings ratio of 10.76, a PEG ratio of 1.47 and a beta of 1.14. McKesson has a 52 week low of $106.11 and a 52 week high of $153.30. The company has a debt-to-equity ratio of 1.14, a quick ratio of 0.58 and a current ratio of 1.01.
McKesson (NYSE:MCK) last announced its quarterly earnings data on Wednesday, July 31st. The company reported $3.31 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $3.04 by $0.27. The business had revenue of $55.73 billion during the quarter, compared to analysts’ expectations of $54.03 billion. McKesson had a return on equity of 30.73% and a net margin of 0.27%. The firm’s quarterly revenue was up 5.9% compared to the same quarter last year. During the same quarter in the previous year, the business earned $2.90 earnings per share. As a group, sell-side analysts predict that McKesson will post 14.39 EPS for the current fiscal year.
In other news, SVP Sundeep G. Reddy sold 422 shares of the business’s stock in a transaction on Monday, September 9th. The stock was sold at an average price of $143.79, for a total value of $60,679.38. Following the completion of the transaction, the senior vice president now owns 1,268 shares in the company, valued at $182,325.72. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Lori A. Schechter sold 1,275 shares of the business’s stock in a transaction on Thursday, October 17th. The stock was sold at an average price of $150.00, for a total value of $191,250.00. Following the completion of the transaction, the executive vice president now owns 1,275 shares of the company’s stock, valued at approximately $191,250. The disclosure for this sale can be found here. Insiders sold 11,493 shares of company stock valued at $1,612,988 in the last 90 days. Company insiders own 0.88% of the company’s stock.
McKesson Company Profile
McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates in three segments: U.S. Pharmaceutical and Specialty Solutions, European Pharmaceutical Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs, as well as other healthcare-related products; and offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices.
Featured Story: How Does the Quiet Period Work?
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.